Axmed

Axmed We believe access to medicines should be equal for all. We bring an innovative marketplace to empower emerging markets to access medicines more competitively.

Imagine a world where critical medicines are within reach, affordable, and synonymous with quality, no matter where you are. That's the world we're building with our unique, demand-aggregation model that unites healthcare providers across LMICs. At the heart of our identity is a resolute commitment: to build a future where geography and income never stand between any individual and life-saving medicines. Our platform isn't merely a space for transactions, we unlock affordable access to medicines by aggregating demand across healthcare providers. We also help manufacturers build a sustainable and reliable global access strategy. Our business focuses on LMICs and strengthens the purchasing power of these markets to ensure the supply of cost-effective, high-quality medicines. We partner exclusively with authorized, high-quality pharmaceutical companies and certified caregivers to accelerate access to medicines.

Africa’s regulatory landscape is moving quickly.At PharmaReg AfriSummit 2026, our team joined regulators, manufacturers ...
10/08/2026

Africa’s regulatory landscape is moving quickly.

At PharmaReg AfriSummit 2026, our team joined regulators, manufacturers and technology partners to discuss the progress being made across the continent, from greater regulatory harmonisation and reliance to stronger national authorities and the growing use of digital systems.

We came away encouraged by how much of the conversation has shifted towards implementation: how these developments can make regulatory processes more efficient, reduce unnecessary duplication and ultimately help quality-assured medicines reach patients faster.

But there is another question we think deserves just as much attention: 𝘄𝗵𝗮𝘁 𝗵𝗮𝗽𝗽𝗲𝗻𝘀 𝗮𝗳𝘁𝗲𝗿 𝗮 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗿𝗲𝗰𝗲𝗶𝘃𝗲𝘀 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹?

Approval can open a market, but there are still significant barriers between an approved product and the patient who needs it.

This is why conversations about regulation, procurement, financing, logistics and technology increasingly need to connect.

At Axmed, we see the opportunity to bring more of that information together, connecting demand with quality supply, increasing visibility through procurement and carrying regulatory requirements into the transaction and delivery process.

Dr. Onyango Michael explores this question in more depth in his latest thought leadership article, reflecting on what he heard at AfriSummit and why the next phase of regulatory progress must consider the full journey medicines take after approval.

Read Michael’s perspective at the link in bio.



09/17/2026

Since launching Axmed’s Global Health Advisory, one question continues to shape our work: how do we make patient access a reality?

Whether we’re helping clients bring innovative therapies to new markets, designing financing strategies, or embedding access earlier in product development, our goal remains the same: maximizing patient impact.

▶️ Watch the video to hear directly from the team about their approach, and what’s ahead.

What does it take to turn a promising healthcare innovation into sustainable patient access?It’s a challenge that many o...
06/25/2026

What does it take to turn a promising healthcare innovation into sustainable patient access?

It’s a challenge that many organizations are grappling with across low- and middle-income countries, where success depends just as much on the strategy, partnerships, financing, and delivery models as the product.

That’s why feedback like this from Dr. Patrice Matchaba, Former CEO and Board Member of Gates Medical Research Institute, means so much to our team:

“At GMRI, we engaged Axmed to work with us on the go-to-market/access strategy. Their professionalism, experience, working relationships with our teams and knowledge have been outstanding.”

We’re grateful for the trust our partners place in us and proud to work alongside organizations committed to expanding access to quality healthcare products where they are needed most.

It’s what makes us ‘a global health access partner of choice,’ as another partner recently described us.
Thank you, Dr Patrice Matchaba and our global health partners, for your continued support and collaboration.

In global health, every minute matters. When we noticed too much of our team’s time was being eaten up by repetitive, mu...
05/27/2026

In global health, every minute matters.

When we noticed too much of our team’s time was being eaten up by repetitive, multi-step tasks, we asked ourselves: what if you could just... ask?

In their latest tech blog, CTO Mattia Albergante and Senior Engineer Ángel JimÊnez walk through how our tech team transformed a five-minute journey through multiple screens into a single natural language request to an AI.

If you’re building operational software, working in global health tech, or just thinking about what agentic AI actually looks like in production - this one is worth a read.

Read now at the link in our bio.

In global health, every minute matters. When we noticed too much of our team’s time was being eaten up by repetitive, mu...
05/27/2026

In global health, every minute matters.

When we noticed too much of our team’s time was being eaten up by repetitive, multi-step tasks, we asked ourselves: what if you could just... ask?

In his latest tech blog, CTO Mattia Albergante walks through how our tech team transformed a five-minute journey through multiple screens into a single natural language request to an AI.

If you’re building operational software, working in global health tech, or just thinking about what agentic AI actually looks like in production - this one is worth a read.

Read now at the link in our bio.

This week, team Axmed is on the ground in Geneva for the World Health Assembly.Over the past year, we’ve worked alongsid...
05/18/2026

This week, team Axmed is on the ground in Geneva for the World Health Assembly.

Over the past year, we’ve worked alongside governments, manufacturers, procurers, and partners to strengthen national procurement systems with greater transparency and efficiency.

Whether we're scaling technology-enabled procurement infrastructure, supporting country-led access models, or expanding innovative financing mechanisms for MNCH commodities, the focus remains the same: building systems that help quality-assured medicines reach the people who need them faster, more affordably, and at scale.

We’re looking forward to continuing these conversations at as part of our broader work to help create a future where public procurement systems are stronger, smarter, and built for scale.

Please reach out at [email protected] if you’d like to connect with the team on the ground.

One year ago at the World Health Assembly, we made a commitment.Together with the Gates Foundation, we launched a $10M c...
05/07/2026

One year ago at the World Health Assembly, we made a commitment.

Together with the Gates Foundation, we launched a $10M catalytic co-financing mechanism designed to strengthen public sector procurement capacity for quality-assured maternal, newborn, and child health (MNCH) commodities.

The model saw a 1:1 match on government procurement of MNCH commodities through the Axmed Medicines Platform, designed to help governments move further, faster, and with greater purchasing power.

Later this month, Team Axmed returns to Geneva with ex*****on already underway.

One year on:
🔹 Six governments are now fully active or in the process of onboarding
🔹 Quality-assured MNCH commodities are reaching frontline facilities

What began as a commitment is now translating into real procurement infrastructure, supporting governments to strengthen national systems with greater transparency, efficiency, and control.

As we head back to WHA, we’re looking forward to building on these conversations and continuing to push toward a future where public procurement systems are stronger, smarter, and built for scale.

When you’re building a marketplace designed to improve access to medicines, time matters.But moving fast can’t mean lowe...
04/22/2026

When you’re building a marketplace designed to improve access to medicines, time matters.

But moving fast can’t mean lowering standards. 

When we wanted to find a way to enforce quality standards more efficiently, without compromising rigor. We couldn’t find one, so we built one.

In her latest piece for our tech blog, our co-founder and COO Radley-Searle shares how we’re using AI to turn pharma audits into real-time quality intelligence.

The quality of reporting improved, became more consistent and more comprehensive. As Sofia explains: “What took days, and weeks, now takes minutes.” 

Delve into the details in Sofia’s full piece, where she explains what we built and why it matters at the link in our bio.

Address

Boston, MA

Website

Alerts

Be the first to know and let us send you an email when Axmed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category